全文获取类型
收费全文 | 4042篇 |
免费 | 375篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 175篇 |
妇产科学 | 79篇 |
基础医学 | 440篇 |
口腔科学 | 115篇 |
临床医学 | 373篇 |
内科学 | 832篇 |
皮肤病学 | 132篇 |
神经病学 | 379篇 |
特种医学 | 279篇 |
外科学 | 543篇 |
综合类 | 89篇 |
一般理论 | 3篇 |
预防医学 | 447篇 |
眼科学 | 98篇 |
药学 | 181篇 |
中国医学 | 4篇 |
肿瘤学 | 240篇 |
出版年
2021年 | 39篇 |
2019年 | 51篇 |
2018年 | 48篇 |
2017年 | 64篇 |
2016年 | 54篇 |
2015年 | 69篇 |
2014年 | 90篇 |
2013年 | 155篇 |
2012年 | 153篇 |
2011年 | 158篇 |
2010年 | 127篇 |
2009年 | 157篇 |
2008年 | 156篇 |
2007年 | 202篇 |
2006年 | 190篇 |
2005年 | 190篇 |
2004年 | 174篇 |
2003年 | 149篇 |
2002年 | 144篇 |
2001年 | 93篇 |
2000年 | 57篇 |
1999年 | 81篇 |
1998年 | 126篇 |
1997年 | 110篇 |
1996年 | 107篇 |
1995年 | 79篇 |
1994年 | 81篇 |
1993年 | 67篇 |
1992年 | 42篇 |
1991年 | 49篇 |
1990年 | 56篇 |
1989年 | 78篇 |
1988年 | 74篇 |
1987年 | 74篇 |
1986年 | 58篇 |
1985年 | 56篇 |
1984年 | 60篇 |
1983年 | 39篇 |
1982年 | 58篇 |
1981年 | 49篇 |
1980年 | 38篇 |
1979年 | 34篇 |
1978年 | 34篇 |
1977年 | 41篇 |
1976年 | 39篇 |
1975年 | 29篇 |
1974年 | 40篇 |
1973年 | 44篇 |
1972年 | 35篇 |
1971年 | 28篇 |
排序方式: 共有4454条查询结果,搜索用时 15 毫秒
1.
2.
3.
Infantile Digital Fibroma Treated With Mohs Micrographic Surgery 总被引:2,自引:0,他引:2
John G. Albertini MD Maj USAF MC Michael Jude Welsch MD CPT USA MC Leo A. Conger MD LTC USA MC Lester F. Libow MD COL USA MC Dirk M. Elston MD COL USA MC 《Dermatologic surgery》2002,28(10):959-961
BACKGROUND: Infantile digital fibroma (IDF) is a rare benign fibrous tumor of childhood that frequently recurs despite local excision. Conservative, nonsurgical management may result in regression and/or joint deformity. OBJECTIVE: To describe the histologic features of IDF and discuss a case excised using Mohs micrographic surgery (MMS). METHODS: Case report and review of the clinical, histologic, and ultrastructural features. RESULTS: Characteristic inclusion bodies of actin were identified with hematoxylin and eosin, Masson's trichrome, and rapid actin immunostain. The tumor was debulked and the majority was removed after one stage of MMS, except where the deep margin approached the joint space. The defect healed by secondary intention. At 2 years the patient had no recurrence or functional joint deformity. CONCLUSION: MMS is a surgical treatment option for IDF. 相似文献
4.
5.
6.
Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation—Efficacy and Safety at Five Years 总被引:2,自引:0,他引:2
Christopher J. E. Watson J. Andrew Bradley Peter J. Friend John Firth Craig J. Taylor John R. Bradley Kenneth G. C. Smith Sathia Thiru Neville V. Jamieson Geoff Hale Herman Waldmann Roy Calne 《American journal of transplantation》2005,5(6):1347-1353
Alemtuzumab is a powerful lymphocyte depleting antibody currently being evaluated in solid organ transplantation. This paper describes 5-year results of a single center study of alemtuzumab as induction in renal transplantation. Thirty-three renal transplant recipients received 20 mg alemtuzumab on day 0 and 1, followed by half-dose cyclosporin monotherapy (trough concentration 75-125 ng/mL) from day 3. They were compared in a retrospective contemporaneous-controlled manner with 66 kidney transplant recipients transplanted in the same period and center who received conventional immunosuppression with cyclosporin, azathioprine and prednisolone. In the alemtuzumab group 12% of recipients died compared to 17% in the control group (p = 0.48); likewise graft loss was similar in both groups (21% vs. 26%, respectively, p = 0.58). Incidence of acute rejection was also comparable at 5 years (31.5% vs. 33.6%), although the pattern of rejection was different with 14% patients in the alemtuzumab group experiencing rejection over 1 year post-transplant compared to none in the control group. There was no significant difference between groups in terms of infection or serious adverse events. While acknowledging the limitations of a relatively small single-center study, results suggest that alemtuzumab induction allowed satisfactory long-term patient and graft survival equivalent to that seen with standard triple immunosuppression, while avoiding steroid therapy. 相似文献
7.
8.
9.
10.
HJ Aubin S Tilikete C Laureaux HT Nguyen Hac MC Roullet-Volmi S Troupel D Barrucand 《European psychiatry》1995,10(8)
The aim of this study was to assess alcoholic inpatients' smoking and coffee intake variation following withdrawal. Only moderate smokers (less than 30 cigarettes/day) showed a significant increase of cigarette consumption after alcohol withdrawal. However, their urinary cotinine level did not vary, suggesting a behavioral, and not biological, compensation through smoking following alcohol withdrawal. Heavy smokers (30 cigarettes/day or more) showed no significant clinical or biological variation of smoking behavior. Coffee consumption increased after alcohol withdrawal in all patients, irrespective of smoking habits. 相似文献